Replies to post #233151 on Biotech Values

[jbog]

RVNC's cash is great, their spend not so great. They'll be back in the market prior to any meaningful revenues from their Daxi line. I'm highly suspect that they'll never reap anything meaningful from the filler line.

They'll be back at the till next year.